Y.S.P. Southeast Asia Holding Berhad (KLSE: YSPSAH)
2.430
+0.010 (0.41%)
At close: Sep 6, 2024
YSPSAH Company Description
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, manufactures and trades in generic drugs.
The company operates through three segments: Manufacturing, Trading, and Investment Holding. It manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices.
The company also manufactures aquatic, cosmetic, and biotechnology products, as well as traditional herbal medicines, food supplements, over-the-counter products, and herbal extracts; and offers management services.
The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.
Y.S.P. Southeast Asia Holding Berhad
Country | Malaysia |
Founded | 1987 |
Industry | Pharmaceutical Preparations |
Employees | 1,369 |
CEO | Fang-Hsin Lee |
Contact Details
Address: Menara LGB Kuala Lumpur, 60000 Malaysia | |
Phone | 60 3 7727 6390 |
Website | yspsah.com |
Stock Details
Ticker Symbol | YSPSAH |
Exchange | Bursa Malaysia |
Fiscal Year | January - December |
Reporting Currency | MYR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Fang-Hsin Lee | Chief Executive Officer |